Noah G. Levy's most recent trade in Merrimack Pharmaceuticals Inc was a trade of 100,000 Common Stock done at an average price of $11.9 . Disclosure was reported to the exchange on Jan. 12, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Merrimack Pharmaceuticals Inc | Noah G. Levy | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 11.90 per share. | 12 Jan 2023 | 100,000 | 1,119,586 (8%) | 0% | 11.9 | 1,190,000 | Common Stock |
| Merrimack Pharmaceuticals Inc | Noah G. Levy | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 11.24 per share. | 30 Dec 2022 | 5,300 | 1,019,586 (7%) | 0% | 11.2 | 59,564 | Common Stock |
| Merrimack Pharmaceuticals Inc | Noah G. Levy | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 11.24 per share. | 30 Dec 2022 | 1,300 | 1,014,286 (7%) | 0% | 11.2 | 14,615 | Common Stock |
| Merrimack Pharmaceuticals Inc | Noah G. Levy | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 5.89 per share. | 13 Jul 2022 | 3,095 | 754,108 (5%) | 0% | 5.9 | 18,227 | Common Stock |
| Merrimack Pharmaceuticals Inc | Noah G. Levy | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 5.87 per share. | 11 Jul 2022 | 2,816 | 751,013 (5%) | 0% | 5.9 | 16,516 | Common Stock |
| Merrimack Pharmaceuticals Inc | Noah G. Levy | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 5.97 per share. | 11 Jul 2022 | 700 | 748,197 (5%) | 0% | 6.0 | 4,182 | Common Stock |
| Merrimack Pharmaceuticals Inc | Noah G. Levy | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 5.99 per share. | 07 Jul 2022 | 1,378 | 747,497 (5%) | 0% | 6.0 | 8,249 | Common Stock |
| Merrimack Pharmaceuticals Inc | Noah G. Levy | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 5.99 per share. | 07 Jul 2022 | 1,100 | 746,119 (5%) | 0% | 6.0 | 6,586 | Common Stock |
| Merrimack Pharmaceuticals Inc | Noah G. Levy | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 5.76 per share. | 30 Jun 2022 | 1,550 | 745,019 (5%) | 0% | 5.8 | 8,921 | Common Stock |
| Merrimack Pharmaceuticals Inc | Noah G. Levy | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 5.99 per share. | 23 Jun 2022 | 1,000 | 743,469 (5%) | 0% | 6.0 | 5,990 | Common Stock |
| Merrimack Pharmaceuticals Inc | Noah G. Levy | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 6.00 per share. | 23 Jun 2022 | 500 | 742,469 (5%) | 0% | 6 | 3,000 | Common Stock |
| Merrimack Pharmaceuticals Inc | Noah G. Levy | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 5.97 per share. | 16 Jun 2022 | 515 | 1,012,986 (7%) | 0% | 6.0 | 3,074 | Common Stock |
| Merrimack Pharmaceuticals Inc | Noah G. Levy | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 5.97 per share. | 16 Jun 2022 | 385 | 741,969 (5%) | 0% | 6.0 | 2,298 | Common Stock |
| Merrimack Pharmaceuticals Inc | Noah G. Levy | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 5.45 per share. | 16 Jun 2022 | 297 | 1,012,471 (7%) | 0% | 5.4 | 1,618 | Common Stock |
| Merrimack Pharmaceuticals Inc | Noah G. Levy | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 5.45 per share. | 16 Jun 2022 | 223 | 741,584 (5%) | 0% | 5.4 | 1,215 | Common Stock |
| Merrimack Pharmaceuticals Inc | Noah G. Levy | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 5.17 per share. | 14 Jun 2022 | 11,977 | 1,010,515 (7%) | 0% | 5.2 | 61,961 | Common Stock |
| Merrimack Pharmaceuticals Inc | Noah G. Levy | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 5.17 per share. | 14 Jun 2022 | 8,961 | 740,120 (5%) | 0% | 5.2 | 46,358 | Common Stock |
| Merrimack Pharmaceuticals Inc | Noah G. Levy | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 5.37 per share. | 14 Jun 2022 | 1,659 | 1,012,174 (7%) | 0% | 5.4 | 8,902 | Common Stock |
| Merrimack Pharmaceuticals Inc | Noah G. Levy | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 5.37 per share. | 14 Jun 2022 | 1,241 | 741,361 (5%) | 0% | 5.4 | 6,659 | Common Stock |
| Merrimack Pharmaceuticals Inc | Noah G. Levy | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 5.15 per share. | 10 Jun 2022 | 5,548 | 998,538 (7%) | 0% | 5.1 | 28,566 | Common Stock |
| Merrimack Pharmaceuticals Inc | Noah G. Levy | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 5.15 per share. | 10 Jun 2022 | 4,151 | 731,159 (5%) | 0% | 5.1 | 21,373 | Common Stock |
| Merrimack Pharmaceuticals Inc | Noah G. Levy | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 4.92 per share. | 10 Jun 2022 | 3,653 | 992,990 (7%) | 0% | 4.9 | 17,975 | Common Stock |
| Merrimack Pharmaceuticals Inc | Noah G. Levy | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 4.92 per share. | 10 Jun 2022 | 2,733 | 727,008 (5%) | 0% | 4.9 | 13,448 | Common Stock |
| Merrimack Pharmaceuticals Inc | Noah G. Levy | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 4.48 per share. | 28 Jan 2022 | 11,458 | 723,752 (5%) | 0% | 4.5 | 51,295 | Common Stock |
| Merrimack Pharmaceuticals Inc | Noah G. Levy | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 4.48 per share. | 28 Jan 2022 | 1,505 | 988,623 (7%) | 0% | 4.5 | 6,738 | Common Stock |
| Merrimack Pharmaceuticals Inc | Noah G. Levy | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 5.05 per share. | 28 Jan 2022 | 714 | 989,337 (7%) | 0% | 5.0 | 3,605 | Common Stock |
| Merrimack Pharmaceuticals Inc | Noah G. Levy | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 5.05 per share. | 28 Jan 2022 | 523 | 724,275 (5%) | 0% | 5.0 | 2,641 | Common Stock |
| Merrimack Pharmaceuticals Inc | Noah G. Levy | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 5.01 per share. | 26 Jan 2022 | 19,528 | 696,022 (5%) | 0% | 5.0 | 97,785 | Common Stock |
| Merrimack Pharmaceuticals Inc | Noah G. Levy | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 4.82 per share. | 26 Jan 2022 | 16,272 | 712,294 (5%) | 0% | 4.8 | 78,475 | Common Stock |
| Merrimack Pharmaceuticals Inc | Noah G. Levy | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 4.00 per share. | 10 Jan 2022 | 76,542 | 987,118 (7%) | 0% | 4.0 | 306,023 | Common Stock |
| Merrimack Pharmaceuticals Inc | Noah G. Levy | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 4.00 per share. | 10 Jan 2022 | 14,728 | 676,494 (5%) | 0% | 4.0 | 58,884 | Common Stock |
| Merrimack Pharmaceuticals Inc | Noah G. Levy | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 3.83 per share. | 10 Jan 2022 | 8,719 | 910,576 (6%) | 0% | 3.8 | 33,432 | Common Stock |
| Merrimack Pharmaceuticals Inc | Noah G. Levy | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 3.83 per share. | 10 Jan 2022 | 5,960 | 661,766 (4%) | 0% | 3.8 | 22,853 | Common Stock |
| Merrimack Pharmaceuticals Inc | Noah G. Levy | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 3.82 per share. | 07 Jan 2022 | 5,215 | 901,857 (6%) | 0% | 3.8 | 19,912 | Common Stock |
| Merrimack Pharmaceuticals Inc | Noah G. Levy | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 3.82 per share. | 07 Jan 2022 | 3,565 | 655,806 (4%) | 0% | 3.8 | 13,612 | Common Stock |
| Merrimack Pharmaceuticals Inc | Noah G. Levy | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 4.00 per share. | 01 Dec 2020 | 17,359 | 896,642 (6%) | 0% | 4.0 | 69,420 | Common Stock |
| Merrimack Pharmaceuticals Inc | Noah G. Levy | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 4.00 per share. | 01 Dec 2020 | 12,417 | 652,241 (4%) | 0% | 4.0 | 49,657 | Common Stock |
| Merrimack Pharmaceuticals Inc | Noah G. Levy | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 3.65 per share. | 24 Nov 2020 | 40,278 | 879,283 (6%) | 0% | 3.7 | 147,015 | Common Stock |
| Merrimack Pharmaceuticals Inc | Noah G. Levy | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 3.65 per share. | 24 Nov 2020 | 28,809 | 639,824 (4%) | 0% | 3.7 | 105,153 | Common Stock |
| Merrimack Pharmaceuticals Inc | Noah G. Levy | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 3.65 per share. | 12 Nov 2020 | 32,934 | 839,005 (6%) | 0% | 3.6 | 120,048 | Common Stock |
| Merrimack Pharmaceuticals Inc | Noah G. Levy | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 3.65 per share. | 12 Nov 2020 | 23,556 | 611,015 (4%) | 0% | 3.6 | 85,864 | Common Stock |
| Merrimack Pharmaceuticals Inc | Noah G. Levy | Other, See remarks | Purchase of securities on an exchange or from another person at price $ 3.50 per share. | 13 Aug 2020 | 354 | 806,071 (6%) | 0% | 3.5 | 1,239 | Common Stock |
| Merrimack Pharmaceuticals Inc | Noah G. Levy | Other, See remarks | Purchase of securities on an exchange or from another person at price $ 3.50 per share. | 13 Aug 2020 | 254 | 587,459 (4%) | 0% | 3.5 | 889 | Common Stock |
| Merrimack Pharmaceuticals Inc | Noah G. Levy | Other, See remarks | Purchase of securities on an exchange or from another person at price $ 3.45 per share. | 11 Aug 2020 | 8,186 | 804,551 (6%) | 0% | 3.5 | 28,262 | Common Stock |
| Merrimack Pharmaceuticals Inc | Noah G. Levy | Other, See remarks | Purchase of securities on an exchange or from another person at price $ 3.45 per share. | 11 Aug 2020 | 5,856 | 586,371 (4%) | 0% | 3.5 | 20,218 | Common Stock |
| Merrimack Pharmaceuticals Inc | Noah G. Levy | Other, See remarks | Purchase of securities on an exchange or from another person at price $ 3.49 per share. | 11 Aug 2020 | 1,166 | 805,717 (6%) | 0% | 3.5 | 4,073 | Common Stock |
| Merrimack Pharmaceuticals Inc | Noah G. Levy | Other, See remarks | Purchase of securities on an exchange or from another person at price $ 3.49 per share. | 11 Aug 2020 | 834 | 587,205 (4%) | 0% | 3.5 | 2,913 | Common Stock |